MAY 2022LIFE SCIENCES REVIEW6Over the past several years, life sciences companies have faced mounting pressure from many directions, including increasing regulatory requirements, nonstop technological advances, and intense pricing pressure. And the unprecedented events of the past year only provided more reason to modernize compliance and elevate the value and partnerships within your companies and external stakeholders.In the face of rapidly evolving regulatory and marketplace demands, compliance teams are under constant pressure to do more with less, requiring a fundamental shift that involves the use of technological accelerators. Once these new technologies are up and running, they can not only help drive efficiency and effectiveness, but also help improve a compliance organization's ability to protect its business and deliver measurable value.Such transformative technologies include robotic process automation, natural language processing and generation, predictive analytics, and artificial intelligence and machine learning. Read our full report to learn how these technologies can be (and already have been) used to help modernize and enhance compliance monitoring procedures across the industry.Business interactions with health care professionals continue to receive close scrutiny from regulators, legislators, and the media. And as more of these interactions and fee-for-services arrangements go virtual--a trend accelerated by the COVID-19 pandemic--health care companies will likely need to make additional adjustments to remain compliant with life sciences regulations. In addition to potential violations of laws like the Anti-Kickback Statute and regulations like the Physician Payments Sunshine Act, life sciences companies should evaluate speaker programs, fair market value, and even meals. Download the full PDF to learn what regulators might be looking for.To continue thriving and leading, life sciences companies should meet the industry's new challenges head-on. Now is the ideal time for the compliance function to evolve its focus from hindsight to foresight. The overarching theme for this year's regulatory outlook is for life sciences companies to take a closer look at their compliance activities as an integral part of their overall business strategy.Let us know your thoughts.EDITORIALThe Changing World of Life Sciences RegulationsCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com MAY - 23 - 2022, Vol 03, Issue - 05 Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz
< Page 5 | Page 7 >